167 related articles for article (PubMed ID: 27131597)
21. Endolysosomal environment-responsive photodynamic nanocarrier to enhance cytosolic drug delivery via photosensitizer-mediated membrane disruption.
Lee CS; Park W; Park SJ; Na K
Biomaterials; 2013 Dec; 34(36):9227-36. PubMed ID: 24008035
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of liposomal doxorubicin exhibiting ultrasensitivity against phospholipase A
Tagami T; Ando Y; Ozeki T
Int J Pharm; 2017 Jan; 517(1-2):35-41. PubMed ID: 27865984
[TBL] [Abstract][Full Text] [Related]
23. Liposomes Containing Lipid-Soluble Zn(II)-Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells.
Ayesa U; Gray BD; Pak KY; Chong PL
Mol Pharm; 2017 Jan; 14(1):147-156. PubMed ID: 28043132
[TBL] [Abstract][Full Text] [Related]
24. Ascorbyl palmitate/DSPE-PEG nanocarriers for oral iron delivery: preparation, characterisation and in vitro evaluation.
Zariwala MG; Farnaud S; Merchant Z; Somavarapu S; Renshaw D
Colloids Surf B Biointerfaces; 2014 Mar; 115():86-92. PubMed ID: 24333557
[TBL] [Abstract][Full Text] [Related]
25. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
Li J; Sharkey CC; King MR
Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
28. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
29. Triple Redox Responsive Poly(Ethylene Glycol)-Polycaprolactone Polymeric Nanocarriers for Fine-Controlled Drug Release.
Zhao C; Shao L; Lu J; Zhao C; Wei Y; Liu J; Li M; Wu Y
Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27762492
[TBL] [Abstract][Full Text] [Related]
30. Mesoporous silica-coated gold nanoframes as drug delivery system for remotely controllable chemo-photothermal combination therapy.
Gao Z; Shi T; Li Y; You C; Cheng K; Sun B
Colloids Surf B Biointerfaces; 2019 Apr; 176():230-238. PubMed ID: 30623810
[TBL] [Abstract][Full Text] [Related]
31. Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles.
Lee AL; Wang Y; Pervaiz S; Fan W; Yang YY
Macromol Biosci; 2011 Feb; 11(2):296-307. PubMed ID: 21154473
[TBL] [Abstract][Full Text] [Related]
32. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
[TBL] [Abstract][Full Text] [Related]
33. Food Protein Based Core-Shell Nanocarriers for Oral Drug Delivery: Effect of Shell Composition on in Vitro and in Vivo Functional Performance of Zein Nanocarriers.
Alqahtani MS; Islam MS; Podaralla S; Kaushik RS; Reineke J; Woyengo T; Perumal O
Mol Pharm; 2017 Mar; 14(3):757-769. PubMed ID: 28103046
[TBL] [Abstract][Full Text] [Related]
34. Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAIL in vitro and in vivo.
Riehle RD; Cornea S; Degterev A; Torchilin V
Drug Deliv; 2013 Feb; 20(2):78-85. PubMed ID: 23495715
[TBL] [Abstract][Full Text] [Related]
35. Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites.
Xu F; Zhong H; Chang Y; Li D; Jin H; Zhang M; Wang H; Jiang C; Shen Y; Huang Y
Biomaterials; 2018 Mar; 158():56-73. PubMed ID: 29304403
[TBL] [Abstract][Full Text] [Related]
36. Optimizing Multistep Delivery of PEGylated Tumor-Necrosis-Factor-Related Apoptosis-Inducing Ligand-Toxin Conjugates for Improved Antitumor Activities.
Wei X; Yang X; Zhao W; Xu Y; Pan L; Chen S
Bioconjug Chem; 2017 Aug; 28(8):2180-2189. PubMed ID: 28697305
[TBL] [Abstract][Full Text] [Related]
37. Fully glutathione degradable waterborne polyurethane nanocarriers: Preparation, redox-sensitivity, and triggered intracellular drug release.
Omrani I; Babanejad N; Shendi HK; Nabid MR
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):607-616. PubMed ID: 27770933
[TBL] [Abstract][Full Text] [Related]
38. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo.
Shi C; Gao F; Gao X; Liu Y
Biomed Pharmacother; 2015 Feb; 69():191-200. PubMed ID: 25661357
[TBL] [Abstract][Full Text] [Related]
39. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
40. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
